Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6909078 | 0.86 | DRD1 (0.34) | DRD1 | |
| SCHEMBL6910098 | 0.84 | — | — | |
| SCHEMBL6903990 | 0.83 | DRD1 (0.33) | DRD1 | |
| SCHEMBL6907815 | 0.82 | DRD1 (0.35) | DRD1 | |
| Hydrochloric Acid SCHEMBL6902165 | 0.81 | DRD1 (0.33) | DRD1 | |
| SCHEMBL6908093 | 0.74 | DRD1 (0.37) | DRD1 | |
| SCHEMBL6906667 | 0.69 | ROCK2 (0.32) | — | |
| SCHEMBL4474698 | 0.66 | CYP3A4 (0.46) | DRD1 | |
| SCHEMBL6909605 | 0.64 | DRD1 (0.30) | DRD1 | |
| Hydrochloric Acid SCHEMBL6909075 | 0.64 | DRD1 (0.35) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6730626-B2 | TRANSITION METAL DERIVATIVE CAN REACT TO FORM AN IONIC COMPLEX WITH THE ALUMINOXANE | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2004-05-04 | — | — | US | disclosed |
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | IDEMITSU KOSAN CO. LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | CCNE2, PYM1, AP1M1 | DRD1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.